Appili Therapeutics Presents Update on ATI-1701 Biodefense Vaccine Candidate at IDWeek™ 2024
Breadcrumb Trail Links GlobeNewswire Author of the article: Published Oct 17, 2024 • 4 minute read Article content ATI-1701 provides full protection against lethal tularemia in animal models after one year Company to provide update on tularemia vaccine …